Karyopharm Therapeutics (KPTI) Reports 2013 Year-End Financial Results And Provides Update On Clinical Development Plans
3/5/2014 9:21:00 AM
NATICK, Mass., March 5, 2014 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company focused on the discovery and development of novel first-in-class drugs directed against nuclear transport targets for the treatment of cancer and other major diseases, reported financial results for the year ended December 31, 2013, and also provided an update on its clinical development plans.
Help employers find you! Check out all the jobs and post your resume.
comments powered by